Affluent Medical Sas Stock Net Asset
| AFME Stock | 1.39 0.01 0.72% |
Affluent Medical SAS fundamentals help investors to digest information that contributes to Affluent Medical's financial success or failures. It also enables traders to predict the movement of Affluent Stock. The fundamental analysis module provides a way to measure Affluent Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Affluent Medical stock.
Affluent |
Affluent Medical SAS Company Net Asset Analysis
Affluent Medical's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Affluent Medical Net Asset | 70.03 M |
Most of Affluent Medical's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Affluent Medical SAS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Affluent Medical SAS has a Net Asset of 70.03 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Devices industry. The net asset for all France stocks is notably lower than that of the firm.
Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Affluent Fundamentals
| Return On Equity | -0.36 | |||
| Return On Asset | -0.12 | |||
| Operating Margin | (8.42) % | |||
| Current Valuation | 50.42 M | |||
| Shares Outstanding | 20.6 M | |||
| Shares Owned By Insiders | 3.35 % | |||
| Shares Owned By Institutions | 65.00 % | |||
| Price To Book | 0.99 X | |||
| Price To Sales | 22.19 X | |||
| Gross Profit | (1.29 M) | |||
| EBITDA | (9.87 M) | |||
| Net Income | (14.82 M) | |||
| Cash And Equivalents | 11.41 M | |||
| Total Debt | 17 M | |||
| Book Value Per Share | 1.95 X | |||
| Cash Flow From Operations | (12.36 M) | |||
| Earnings Per Share | (0.77) X | |||
| Target Price | 3.8 | |||
| Number Of Employees | 49 | |||
| Market Capitalization | 30.06 M | |||
| Total Asset | 70.03 M | |||
| Z Score | 0.6 | |||
| Net Asset | 70.03 M |
About Affluent Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Affluent Medical SAS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Affluent Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Affluent Medical SAS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Affluent Stock
Affluent Medical financial ratios help investors to determine whether Affluent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Affluent with respect to the benefits of owning Affluent Medical security.